{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:50:34Z","timestamp":1788328234195,"version":"build-2803163510"},"reference-count":22,"publisher":"Association of Biomolecular Resource Facilities","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2R42GM113666"],"award-info":[{"award-number":["2R42GM113666"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Glycation is an important post-translational modification (PTM) that has been linked to diabetes, cataract, Alzheimer\u2019s, and Rheumatoid arthritis. This reaction occurs between a reducing sugar and a primary amine at the N-terminus of a protein or at a lysine side chain. Ultimately, this interaction can lead to advanced glycation end products (AGEs) that are associated with several disease complications. Glycation can occur during the manufacturing and storage of therapeutic proteins, including monoclonal antibodies (mAbs), necessitating the characterization of this modification to ensure the safety and efficacy of therapeutic drug products. Hydrophilic Interaction Liquid Chromatography (HILIC) has been previously employed to characterize hydrophilic modifications. It can also be used to characterize glycated species, as the hydrophilic nature of the glycation product can lead to a characteristic shift in HILIC retention. This work focuses on deriving a retention coefficient that describes the extent of hydrophilicity imparted by glycation modification in HILIC using in vitro glycated peptide and protein samples. The HILIC retention coefficient can be used to predict the retention times of tryptic peptides with glycation modifications in complex, unknown protein samples, including immunoglobulins (IgGs).<\/jats:p>","DOI":"10.7171\/001c.157968","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:09Z","timestamp":1774038489000},"source":"Crossref","is-referenced-by-count":1,"title":["Prediction and Characterization of Glycated Peptides and Proteins using Hydrophilic Interaction Liquid Chromatography coupled with Mass Spectrometry (HILIC-MS)"],"prefix":"10.7171","volume":"37","author":[{"given":"Sonal","family":"Priya","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02bjhwk41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Georgia","department":["Complex Carbohydrate Research Center"]},{"id":[{"id":"https:\/\/ror.org\/02bjhwk41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Georgia","department":["Department of Chemisty"]},{"id":[{"id":"https:\/\/ror.org\/05by5hm18","id-type":"ROR","asserted-by":"publisher"}],"name":"California State Polytechnic University","department":["Chemistry and Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L","family":"Kowalski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02bjhwk41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Georgia","department":["Complex Carbohydrate Research Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Popov","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/045xnm641","id-type":"ROR","asserted-by":"publisher"}],"name":"GlycoScientific (United States)","department":["Research"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-8326","authenticated-orcid":false,"given":"Ron","family":"Orlando","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02bjhwk41","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Georgia","department":["Complex Carbohydrate Research Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4185","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ab.2007.09.027","article-title":"A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior","volume":"373","author":"C. Quan","year":"2008","journal-title":"Anal Biochem"},{"issue":"12","key":"ref2","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1002\/jps.21749","article-title":"The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies","volume":"98","author":"D. D. Banks","year":"2009","journal-title":"J Pharm Sci"},{"issue":"7","key":"ref3","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/jps.22504","article-title":"Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody","volume":"100","author":"A.K. Miller","year":"2011","journal-title":"J Pharm Sci"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/jc.2017-01551","article-title":"Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes","volume":"103","author":"S. R. Kashyap","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1021\/ac701810q","article-title":"Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody","volume":"80","author":"B. Zhang","year":"2008","journal-title":"Anal Chem"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/glycob\/cwr141","article-title":"Rates and impact of human antibody glycation in vivo","volume":"22","author":"A. M. Goetze","year":"2012","journal-title":"Glycobiology"},{"issue":"24","key":"ref7","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1021\/ac7017469","article-title":"Characterization of nonenzymatic glycation on a monoclonal antibody","volume":"79","author":"L. J. Brady","year":"2007","journal-title":"Anal Chem"},{"issue":"4","key":"ref8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/19420862.2017.1300214","article-title":"Glycation of antibodies: modification, methods and potential effects on biological functions","volume":"9","author":"B. Wei","year":"2017","journal-title":"mAbs"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jasms.2003.11.014","article-title":"Enzymatic digestion and mass spectrometry in the study of advanced glycation end products\/peptides","volume":"15","author":"A. Lapolla","year":"2004","journal-title":"J Am Soc Mass Spectrom"},{"issue":"19","key":"ref10","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1007\/s00216-018-1561-1","article-title":"A generic workflow for the characterization of therapeutic monoclonal antibodies\u2014application to daratumumab","volume":"411","author":"B. L. Duivelshof","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"ref11","article-title":"Biopharmaceuticals market size & share analysis \u2013 trends, drivers, competitive landscape, and forecasts (2024\u20132030)","year":"2024"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.chroma.2017.12.055","article-title":"Peptide retention prediction using hydrophilic interaction liquid chromatography coupled to mass spectrometry","volume":"1537","author":"M. J. Badgett","year":"2018","journal-title":"J Chromatogr A"},{"issue":"5","key":"ref13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/microorganisms12050946","article-title":"Characterizing glycosylation of adeno-associated virus Serotype 9 capsid proteins generated from HEK293 cells through glycopeptide mapping and released glycan analysis","volume":"12","author":"Y. Zhou","year":"2024","journal-title":"Microorganisms"},{"issue":"1-2","key":"ref14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cccn.2004.03.026","article-title":"In vitro glycation of human immunoglobulin G","volume":"345","author":"A. Vrdoljak","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"1-3","key":"ref15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10616-007-9075-2","article-title":"Modifications of therapeutic proteins: challenges and prospects","volume":"53","author":"N. Jenkins","year":"2007","journal-title":"Cytotechnology"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biotechadv.2011.05.006","article-title":"Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics","volume":"30","author":"I. A. Kaltashov","year":"2012","journal-title":"Biotechnol Adv"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/rheumatology\/37.12.1307","article-title":"A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE","volume":"37","author":"S. Ligier","year":"1998","journal-title":"Br J Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"M. Brownlee","year":"1995","journal-title":"Annu Rev Med"},{"key":"ref19","first-page":"66","article-title":"Action of amino acids on sugars. Formation of melanoidins in a methodical way","volume":"154","author":"L. C. Maillard","year":"1912","journal-title":"Compt Rend"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.2478\/V10133-010-0066-7","article-title":"Non-enzymatic glycosylation and deglycating enzymes","volume":"24","author":"E. A. Popova","year":"2010","journal-title":"Biotechnol Biotechnol Equip"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/DMSO.S63089","article-title":"Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management","volume":"8","author":"S. Palimeri","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnins.2018.00381","article-title":"Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in Parkinson's disease","volume":"12","author":"P. A. Q. Videira","year":"2018","journal-title":"Front Neurosci"}],"container-title":["Journal of Biomolecular Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jbt.abrf.org\/article\/157968-prediction-and-characterization-of-glycated-peptides-and-proteins-using-hydrophilic-interaction-liquid-chromatography-coupled-with-mass-spectrometry","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:09Z","timestamp":1774038489000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbt.abrf.org\/article\/157968-prediction-and-characterization-of-glycated-peptides-and-proteins-using-hydrophilic-interaction-liquid-chromatography-coupled-with-mass-spectrometry"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.7171\/001c.157968","relation":{},"ISSN":["1524-0215"],"issn-type":[{"value":"1524-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}